{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:07:37Z","timestamp":1788361657886,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04017-0","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:46:29Z","timestamp":1742697989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of potential biomarkers and therapeutic targets in psoriasis based on NF-\u03baB pathway-related genes"],"prefix":"10.1007","volume":"317","author":[{"given":"Fang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"4017_CR1","doi-asserted-by":"crossref","unstructured":"Walter K, Psoriasis (2022) Jama. 327:1936","DOI":"10.1001\/jama.2022.5270"},{"key":"4017_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R (2021) Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397:754\u2013766","journal-title":"Lancet"},{"key":"4017_CR3","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","volume":"9","author":"L Tang","year":"2018","unstructured":"Tang L, Yang X, Liang Y, Xie H, Dai Z, Zheng G (2018) Transcription factor retinoid-related orphan receptor \u03b3t: a Promising Target for the treatment of Psoriasis. Front Immunol 9:1210","journal-title":"Front Immunol"},{"key":"4017_CR4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol 182:840\u2013848","journal-title":"Br J Dermatol"},{"key":"4017_CR5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaci.2015.06.009","volume":"136","author":"K Yamanaka","year":"2015","unstructured":"Yamanaka K, Mizutani H (2015) Inflammatory skin march: IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events. J Allergy Clin Immunol 136:823\u2013824","journal-title":"J Allergy Clin Immunol"},{"key":"4017_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjd.21627","volume":"187","author":"R Ramessur","year":"2022","unstructured":"Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N et al (2022) Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol 187:481\u2013493","journal-title":"Br J Dermatol"},{"key":"4017_CR7","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jid.2017.05.023","volume":"137","author":"JC Prinz","year":"2017","unstructured":"Prinz JC, Melanocytes (2017) Target cells of an HLA-C*06:02-Restricted autoimmune response in Psoriasis. J Invest Dermatol 137:2053\u20132058","journal-title":"J Invest Dermatol"},{"key":"4017_CR8","doi-asserted-by":"crossref","unstructured":"Tokuyama M, Mabuchi T (2020) New Treatment addressing the pathogenesis of Psoriasis. Int J Mol Sci. 21","DOI":"10.3390\/ijms21207488"},{"key":"4017_CR9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jdv.16803","volume":"35","author":"A Al-Hammadi","year":"2021","unstructured":"Al-Hammadi A, Ruszczak Z, Magari\u00f1os G, Chu CY, El Dershaby Y, Tarcha N (2021) Intermittent use of biologic agents for the treatment of psoriasis in adults. J Eur Acad Dermatol Venereol 35:360\u2013367","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4017_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","volume":"392","author":"KB Gordon","year":"2018","unstructured":"Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y et al (2018) Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials. Lancet 392:650\u2013661","journal-title":"Lancet"},{"key":"4017_CR11","doi-asserted-by":"crossref","unstructured":"Pflug KM, Sitcheran R (2020) Targeting NF-\u03baB-Inducing kinase (NIK) in immunity, inflammation, and Cancer. Int J Mol Sci. 21","DOI":"10.3390\/ijms21228470"},{"key":"4017_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5:209","journal-title":"Signal Transduct Target Ther"},{"key":"4017_CR13","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023","journal-title":"Signal Transduct Target Ther"},{"key":"4017_CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/10715762.2016.1162301","volume":"50","author":"X Lin","year":"2016","unstructured":"Lin X, Huang T (2016) Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res 50:585\u2013595","journal-title":"Free Radic Res"},{"key":"4017_CR15","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1038\/ncomms8454","volume":"6","author":"M Hara-Chikuma","year":"2015","unstructured":"Hara-Chikuma M, Satooka H, Watanabe S, Honda T, Miyachi Y, Watanabe T et al (2015) Aquaporin-3-mediated hydrogen peroxide transport is required for NF-\u03baB signalling in keratinocytes and development of psoriasis. Nat Commun 6:7454","journal-title":"Nat Commun"},{"key":"4017_CR16","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.7150\/ijbs.92514","volume":"20","author":"J Zhao","year":"2024","unstructured":"Zhao J, Chen Y, Li L, Yin H, Song S, Wang Y et al (2024) CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-\u03baB signaling for the treatment of psoriasis. Int J Biol Sci 20:2168\u20132186","journal-title":"Int J Biol Sci"},{"key":"4017_CR17","doi-asserted-by":"crossref","unstructured":"Wang Y, Chen W, Li K, Wu G, Zhang W, Ma P et al (2021) Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA. Biosci Rep. 41","DOI":"10.1042\/BSR20211476"},{"key":"4017_CR18","doi-asserted-by":"crossref","unstructured":"Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y (2021) Three Differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2. J Vis Exp.","DOI":"10.3791\/62528-v"},{"key":"4017_CR19","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M (2022) Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38:3844\u20133846","journal-title":"Bioinformatics"},{"key":"4017_CR20","doi-asserted-by":"crossref","first-page":"1162458","DOI":"10.3389\/fimmu.2023.1162458","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhuang H, Jiang XH, Zou RH, Wang HY, Fan ZN (2023) Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis. Front Immunol 14:1162458","journal-title":"Front Immunol"},{"key":"4017_CR21","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lu F, Yin Y (2022) Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease. Sci Rep 12:11340","journal-title":"Sci Rep"},{"key":"4017_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC et al (2011) pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics 12:77","journal-title":"BMC Bioinformatics"},{"key":"4017_CR23","doi-asserted-by":"crossref","first-page":"e16447","DOI":"10.7717\/peerj.16447","volume":"11","author":"Q Tian","year":"2023","unstructured":"Tian Q, Liu X, Li A, Wu H, Xie Y, Zhang H et al (2023) LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration. PeerJ 11:e16447","journal-title":"PeerJ"},{"key":"4017_CR24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.21037\/atm-22-3700","volume":"10","author":"K Li","year":"2022","unstructured":"Li K, Liu P, Zhang W, Liu X, Tanino Y, Koga Y et al (2022) Bioinformatic identification and analysis of immune-related chromatin regulatory genes as potential biomarkers in idiopathic pulmonary fibrosis. Ann Transl Med 10:896","journal-title":"Ann Transl Med"},{"key":"4017_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Li R, Zhou H, Chang X (2024) New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cell Mol Biol Lett 29:21","journal-title":"Cell Mol Biol Lett"},{"key":"4017_CR26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J, Psoriasis (2021) Lancet 397:1301\u20131315","journal-title":"Lancet"},{"key":"4017_CR27","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4049\/jimmunol.2100577","volume":"208","author":"J Huang","year":"2022","unstructured":"Huang J, Feng X, Zeng J, Zhang S, Zhang J, Guo P et al (2022) Aberrant HO-1\/NQO1-Reactive oxygen Species-ERK Signaling Pathway contributes to aggravation of TPA-Induced Irritant Contact Dermatitis in Nrf2-Deficient mice. J Immunol 208:1424\u20131433","journal-title":"J Immunol"},{"key":"4017_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.12.085","volume":"591","author":"Y Ge","year":"2022","unstructured":"Ge Y, Luo J, Li D, Li C, Huang J, Yu H et al (2022) Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced scleroderma. Biochem Biophys Res Commun 591:1\u20136","journal-title":"Biochem Biophys Res Commun"},{"key":"4017_CR29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12874-016-0254-8","volume":"16","author":"MM Vasquez","year":"2016","unstructured":"Vasquez MM, Hu C, Roe DJ, Chen Z, Halonen M, Guerra S (2016) Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol 16:154","journal-title":"BMC Med Res Methodol"},{"key":"4017_CR30","doi-asserted-by":"crossref","first-page":"954848","DOI":"10.3389\/fimmu.2022.954848","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, He S, Yu X, Lai X, Tang S, Mariya ME et al (2022) Analysis and experimental validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and pan-cancer. Front Immunol 13:954848","journal-title":"Front Immunol"},{"key":"4017_CR31","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/emboj.2009.183","volume":"28","author":"S Marchetti","year":"2009","unstructured":"Marchetti S, Gamas P, Belhac\u00e8ne N, Grosso S, Pradelli LA, Colosetti P et al (2009) The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. Embo j 28:2449\u20132460","journal-title":"Embo j"},{"key":"4017_CR32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1515\/hsz-2021-0250","volume":"402","author":"S Hailfinger","year":"2021","unstructured":"Hailfinger S, Schulze-Osthoff K (2021) The paracaspase MALT1 in psoriasis. Biol Chem 402:1583\u20131589","journal-title":"Biol Chem"},{"key":"4017_CR33","doi-asserted-by":"crossref","first-page":"eabi4425","DOI":"10.1126\/sciimmunol.abi4425","volume":"6","author":"Z Kurgyis","year":"2021","unstructured":"Kurgyis Z, Vornholz L, Pechloff K, Kem\u00e9ny LV, Wartewig T, Muschaweckh A et al (2021) Keratinocyte-intrinsic BCL10\/MALT1 activity initiates and amplifies psoriasiform skin inflammation. Sci Immunol 6:eabi4425","journal-title":"Sci Immunol"},{"key":"4017_CR34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","volume":"17","author":"IS Afonina","year":"2016","unstructured":"Afonina IS, Van Nuffel E, Baudelet G, Driege Y, Kreike M, Staal J et al (2016) The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes. EMBO Rep 17:914\u2013927","journal-title":"EMBO Rep"},{"key":"4017_CR35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bcp.2016.06.001","volume":"115","author":"F Shao","year":"2016","unstructured":"Shao F, Tan T, Tan Y, Sun Y, Wu X, Xu Q (2016) Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88. Biochem Pharmacol 115:94\u2013103","journal-title":"Biochem Pharmacol"},{"key":"4017_CR36","doi-asserted-by":"crossref","first-page":"112082","DOI":"10.1016\/j.intimp.2024.112082","volume":"133","author":"L Liu","year":"2024","unstructured":"Liu L, Zhang H, Tang X, Zhang M, Wu Y, Zhao Y et al (2024) Geniposide ameliorates psoriatic skin inflammation by inhibiting the TLR4\/MyD88\/NF-\u03baB p65 signaling pathway and MMP9. Int Immunopharmacol 133:112082","journal-title":"Int Immunopharmacol"},{"key":"4017_CR37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","volume":"12","author":"Y Shou","year":"2021","unstructured":"Shou Y, Yang L, Yang Y, Xu J (2021) Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis 12:1009","journal-title":"Cell Death Dis"},{"key":"4017_CR38","doi-asserted-by":"crossref","first-page":"e13577","DOI":"10.1111\/srt.13577","volume":"30","author":"L Fu","year":"2024","unstructured":"Fu L, Li M, Wang P, Chen L, Huang J, Zhang H, Tanshinone IIA (2024) A component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17\/IL-23 and PTGS2\/NF-\u03baB\/AP-1 pathways. Skin Res Technol 30:e13577","journal-title":"Skin Res Technol"},{"key":"4017_CR39","doi-asserted-by":"crossref","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 20","DOI":"10.3390\/ijms20061475"},{"key":"4017_CR40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"JL Harden","year":"2015","unstructured":"Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66\u201373","journal-title":"J Autoimmun"},{"key":"4017_CR41","first-page":"97","volume":"93","author":"F Gr\u00e4n","year":"2020","unstructured":"Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K (2020) Current developments in the Immunology of Psoriasis. Yale J Biol Med 93:97\u2013110","journal-title":"Yale J Biol Med"},{"key":"4017_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","volume":"50","author":"JQ Chen","year":"2016","unstructured":"Chen JQ, Szodoray P, Zeher M (2016) Toll-like receptor pathways in Autoimmune diseases. Clin Rev Allergy Immunol 50:1\u201317","journal-title":"Clin Rev Allergy Immunol"},{"key":"4017_CR43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S et al (2016) Quercetin, inflammation and immunity. Nutrients 8:167","journal-title":"Nutrients"},{"key":"4017_CR44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","volume":"48","author":"H Chen","year":"2017","unstructured":"Chen H, Lu C, Liu H, Wang M, Zhao H, Yan Y et al (2017) Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway. Int Immunopharmacol 48:110\u2013117","journal-title":"Int Immunopharmacol"},{"key":"4017_CR45","doi-asserted-by":"crossref","first-page":"40228","DOI":"10.1021\/acsami.3c07582","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gong S, Liu L, Shen H, Liu E, Pan L et al (2023) Cyclodextrin-coordinated liposome-in-gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment. ACS Appl Mater Interfaces 15:40228\u201340240","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04017-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04017-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:46:51Z","timestamp":1742698011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04017-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04017-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"615"}}